Adaptive Biotechnologies

ADPT NASDAQ
Overview Stats Financials News

Price & Volume

Stats

See more
52W Range $2.28-$8.51
Market Cap $461.2M
Shares Short 13M

Financials

See more
Revenue (12 Mos) $174.5M
Revenue Growth (YoY) 11.2%
Gross Profit (12 Mos) -$13.6M
Diluted EPS -$1.49

About

CEO Mr. Chad M. Robins M.B.A.
CFO Mr. Kyle Piskel
Address 1165 Eastlake Avenue East, Seattle, WA, United States, 98109
Sector Healthcare
Industry Biotechnology
Full-Time Employees 709